Recent Updates
Recently added Catalysts
CLNN Positive Sentiment

Clene to Present at the 37TH Annual Roth Conference

Thursday, March 6, 2025 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Clene Inc. announced its participation at the 37th Annual Roth Conference, set for March 18, 2025. Management will engage in a virtual fireside chat and also offer one-on-one investor meetings. This event underscores Clene's focus on developing treatments for neurodegenerative diseases like ALS and MS. Information regarding the webcast can be found on the Clene website's events section.
Price reaction · baseline $4.4 (2025-03-05 close) · hit after-hours · clean, no other CLNN news in the window
day 0 close · peak
+3%

Market Sentiment Analysis

POSITIVE FACTORS

  • Clene is actively engaging with investors at the Roth Conference.
  • The company's focus on neurodegenerative diseases highlights its commitment to innovative treatments.
  • A virtual format allows broader access for interested parties.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+63%
120-day peak, hindsight
Typical move
5.3%
average across 6 past catalysts
Cash runway
~11 mo
Medium dilution risk
Lead asset
CNMAu8
Phase 2 · Amyotrophic Lateral Sclerosis

Full Press Release Details

SALT LAKE CITY, March 06, 2025 (GLOBE NEWSWIRE) -- Clene Inc. (Nasdaq: CLNN) (along with its subsidiaries, “Clene”) and its wholly owned subsidiary Clene Nanomedicine Inc., a late clinical-stage biopharmaceutical company focused on revolutionizing the treatment of neurodegenerative diseases, including amyotrophic lateral sclerosis (ALS) and multiple sclerosis (MS), today announced that management will participate in a fireside chat at the 37th Annual Roth Conference and host 1x1 investor meetings.
Date: March 18, 2025
Time of Presentation: 9:20 am PST
Format: Virtual Fireside Chat
1x1 Meetings: Please contact your Roth representative.
A webcast of the presentation will be available on the “Events” section of the Clene website. Alternatively, one can register online to view the webcast here: link.

Frequently Asked Questions

What is Clene Inc. focused on?

Clene Inc. aims to revolutionize treatments for neurodegenerative diseases.

When is Clene's fireside chat scheduled?

The fireside chat is scheduled for March 18, 2025, at 9:20 am PST.

Where can I watch the webcast of the presentation?

The webcast will be available in the 'Events' section on Clene's website.

Who should I contact for 1x1 meetings?

Please contact your Roth representative for 1x1 investor meetings.

ShareAdd on Google
Tags: CLNN Viatris Investor Conferences Healthcare Clene Inc. neurodegenerative diseases Roth Conference ALS MS
Last updated: Mar 6, 2025

Biotech snapshot

Cash runway
$10M liquidity · $1M/mo burn
~11 mo
Medium dilution risk
Lead asset
CNMAu8Phase 2
Amyotrophic Lateral Sclerosis →

Catalyst track record

+63%
best trade around CLNN's most recent catalyst

Peak hindsight return over a 120-day window, across 6 tracked FDA/PDUFA catalysts for CLNN.

See every catalyst's timing & PoA →